CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk Healthcare Dr. Agarwals Health Care Ltd

Dr. Agarwals Health Care Ltd

BSE 544350 AGARWALEYE INE943P01029
Healthcare Healthcare Healthcare Services Hospital

Filing rhythm · 60 trading days

26 filings · 5 material · busiest 2026-07-02 and 2026-08-14

What it files

Filings

26 in the window

  1. 25 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  2. 25 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Investors Meet is submitted.

    Company Update / Analyst / Investor Meet View filing →

  3. 14 August 2026

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  4. 14 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  5. 14 August 2026

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  6. 14 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hyperion Investments Pte Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  7. 14 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Claymore Investments (Mauritius) Pte Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  8. 14 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DB International Trust (Singapore) Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  9. 7 August 2026

    Concall Transcript

    Earnings Call Transcript

    Transcript of the discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, at the analyst call held on August 04, ....

    Company Update / Earnings Call Transcript View filing →

  10. 4 August 2026

    Board Outcome

    Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter Ended June 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Outcome of the Meeting of the Board of Directors of the Company held on August 04, 2026, is attached.

    Board Meeting / Outcome of Board Meeting View filing →

  11. 4 August 2026

    Results

    Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026.

    Consolidated and Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2026 is submitted.

    Result / Financial Results View filing →

  12. 4 August 2026

    Investor Presentation

    Investor Presentation

    Presentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, is attached.

    Company Update / Investor Presentation View filing →

  13. 4 August 2026

    Monitoring Agency

    Monitoring Agency Report

    Dr. Agarwal's Health Care Limited - Monitoring Agency Report for the quarter ended June 30, 2026, is submitted.

    Company Update / Monitoring Agency Report View filing →

  14. 4 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Link for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30, ....

    Company Update / Analyst / Investor Meet View filing →

  15. 28 July 2026

    Board Meeting

    Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026

    Dr. Agarwals Health Care Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

    Board Meeting / Board Meeting View filing →

  16. 28 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Analyst / Earnings Conference call to discuss the Unaudited Financial Results (Standalone & Consolidated) of the Company For The Quarter Ended June 30, 2026, is attached

    Company Update / Analyst / Investor Meet View filing →

  17. 20 July 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement of Notice of Hearing of the Company's Petition in relation to the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care ....

    Company Update / Newspaper Publication View filing →

  18. 9 July 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    Allotment of 43,155 Equity Shares pursuant to the exercise of options granted under Dr. Agarwal's Health Care Limited - Employee Stock Option Scheme 2022.

    Company Update / Allotment of ESOP / ESPS View filing →

  19. 7 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026 is enclosed.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  20. 2 July 2026

    Court Convened Meeting

    Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting

    Summary of the Proceedings of the NCLT convened meeting of the Equity Shareholders of Dr Agarwal's Health Care Limited held on July 02, 2026

    AGM/EGM / Court Convened Meeting View filing →

  21. 2 July 2026

    Court Convened Meeting

    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Voting Results and the Consolidated Scrutinizer's Report on the Hon'ble NCLT convened meeting of the Equity Shareholders of Dr. Agarwal's Health Care Limited held on July 02, 2026

    AGM/EGM / Court Convened Meeting View filing →

  22. 2 July 2026

    General

    Summary Of The Proceedings Of The Hon'ble NCLT Convened Meeting Of The Secured Creditors Of Dr. Agarwal's Health Care Limited Held On July 02, 2026

    Summary of the Proceedings of the Hon'ble NCLT convened meeting of the Secured Creditors of Dr. Agarwal's Health Care Limited held on July 02, 2026, is enclosed.

    Company Update / General View filing →

  23. 2 July 2026

    General

    Voting Results And The Consolidated Scrutinizer's Report On The NCLT Convened Meeting Of The Equity Shareholders Of Dr. Agarwal's Health Care Limited Held On July 02, 2026.

    Voting Results and the Consolidated Scrutinizer's Report on the Hon'ble NCLT convened meeting of the Equity Shareholders of Dr. Agarwal's Health Care Limited held on July 02, 2026, is enclosed.

    Company Update / General View filing →

  24. 2 July 2026

    General

    Summary Of The Proceedings Of The Hon'ble NCLT Convened Meeting Of The Unsecured Creditors Of Dr. Agarwal's Health Care Limited Held On July 02, 2026

    Summary of the Proceedings of the Hon'ble NCLT convened meeting of the Unsecured Creditors of Dr. Agarwal's Health Care Limited held on July 02, 2026, is enclosed.

    Company Update / General View filing →

  25. 2 July 2026

    General

    Voting Results And The Consolidated Scrutinizer's Report On The Hon'ble NCLT Convened Meeting Of The Unsecured Creditors Of Dr. Agarwal's Health Care Limited Held On July 02, 2026.

    Voting Results and the Consolidated Scrutinizer's Report on the Hon'ble NCLT convened meeting of the unsecured creditors of Dr. Agarwal's Health Care Limited held on July 02, 2026, is enclosed.

    Company Update / General View filing →

  26. 16 June 2026

    Credit Rating

    Credit Rating

    Re-affirmation and Withdrawal of Credit Rating by CRISIL Ratings Limited with respect to the debt facilities availed by the Company, is enclosed.

    Company Update / Credit Rating View filing →